Skip to main content

Pathway · Menopause after cancer

Menopause without MHT isn't the end of the road.

Tamoxifen, aromatase inhibitors, surgical menopause from cancer surgery, chemo-induced menopause, all of it lands harder than usual menopause and with the standard rescue option, systemic MHT, often off the table. The toolkit is smaller. It's not empty.

Start here

Three doors, depending on where you are right now.

Mid-treatment

Is this safe with my cancer treatment?

Profile-aware look-up for supplements, herbs and medications against tamoxifen, AIs, CDK4/6, PARP and platinum chemo.

Open the checker

Symptoms are loud

Hot flashes, sleep, GSM, mood — what helps?

Eight non-hormonal options that are well-evidenced and routinely under-offered after hormone-sensitive cancer.

See what helps

Earlier in the decision

Does MHT actually raise my cancer risk?

Breast, endometrial and ovarian — in absolute numbers, by formulation and duration. The honest-numbers page.

MHT and cancer risk

The short version

  • Symptoms are often more severe because the change is faster.
  • Non-hormonal options for hot flashes are real, evidence-based, and underused.
  • Elinzanetant (Lynkuet) is now authorized in Canada for people on endocrine therapy for breast cancer, though nobody is publicly paying for it yet.
  • Vaginal estrogen after breast cancer is a nuanced conversation, not always a flat no.
  • GSM, mental health and bone need active care, not 'just push through'.
  • Find an oncology-aware menopause doctor or specialist. They exist.

Menopause after a hormone-sensitive cancer (breast, endometrial, ovarian) is a different conversation. Vasomotor symptoms tend to be more severe because of the speed of the change. Mood, sleep, joints and genitourinary syndrome of menopause (GSM) all show up at once. And the answer most other people get, 'try HRT', is either contraindicated or a much more careful discussion. The non-hormonal evidence base has actually grown a lot in the last few years (cognitive behavioural therapy (CBT) for hot flashes, SSRIs/SNRIs, gabapentin, fezolinetant) and the picture for vaginal estrogen after breast cancer is more nuanced than the blanket 'no' you may have been given. This page is the map for what's left, and it's more than you've probably been told.

What people reported

The care gap shows up before treatment starts.

In a 2025 online survey by Menopause and Cancer, more than 1,300 people who experienced menopause following cancer treatment described the information and support they received. This was a community survey of respondents' experiences, not a clinical study or a representative population estimate.

95%
reported inadequate support from their healthcare team
92%
reported having no pre-treatment menopause-management plan
74%
reported inadequate information about treatment-induced menopause
80%
reported inadequate pre-treatment discussion of menopause impacts

These figures describe the people who chose to answer this survey. They still point to practical questions worth asking before treatment: what symptoms might change, who will manage them, and what the plan is if they become difficult to live with.

Read the full survey results

01 · The physiology

What's actually going on

Cancer-induced menopause has its own physiology and its own social context. Both deserve naming.

02 · What helps

What people actually find helps

Most of this is well-evidenced and routinely under-offered. None of it requires systemic MHT.

03 · Signals worth watching

Signals worth paying attention to

Survivorship menopause care benefits from steady measurement, the small changes you log are what makes the next consult productive.

04 · Don't normalize these

When to escalate

Survivorship is the long tail. Don't normalize things that have answers.

Free cancer support that takes menopause seriously

These are non-profit organizations that offer real survivorship care, counselling, exercise therapy, nutrition, sleep and sexual-health support, free at the point of use. None of them charge to walk in the door.

  • Canada (BC)
    InspireHealth, supportive cancer care , Free, non-profit. Online and in-person (Vancouver, Victoria, Kelowna, Kamloops). Counselling, nutrition, exercise therapy (Be Fit virtual classes, walking groups), sleep and energy, plus the two-day LIFE programme. Open to anyone with a cancer diagnosis and their loved ones.
  • Canada
    Wellspring, cancer support communities , Free programmes across Ontario, Alberta and online: exercise (Cancer Exercise), nutrition, counselling, brain-fog and returning-to-work groups. No referral needed.
  • UK
    Macmillan Cancer Support , Free support line, financial guidance, and local services including exercise programmes, counselling and menopause-after-cancer information.
  • UK
    Maggie's Centres , Drop-in centres next to NHS cancer hospitals. Free psychological support, benefits advice, nutrition and movement groups. No appointment needed.
  • UK
    Menopause and Cancer , Non-profit founded by breast cancer survivor Dani Binnington. Free resources, a large Facebook community, and a weekly podcast with named oncologists and menopause specialists. Practical, oncology-aware, and honest about the trade-offs of MHT and vaginal estrogen after cancer.
  • US
    OncoMenopause , Permanent national education initiative of HERmedicine focused on the intersection of cancer survivorship, menopause and midlife women's health. Free weekly Monday and Wednesday evening virtual education sessions (8–9 p.m. EDT), plus in-person CME events for clinicians. Evidence-based and multidisciplinary.
  • US
    CancerCare , Free professional counselling, support groups (including for survivors managing menopause and sexual health) and financial assistance, by phone and online across the US.
  • Australia
    Cancer Council, 13 11 20 information & support , National support line and an unusually clear plain-English guide to menopause after cancer treatment. Free.
Four episodes worth your Sunday walk

From The Menopause and Cancer Podcast (Dani Binnington). Oncology-aware, honest about trade-offs.

Watch: six-part series

Six-part video series

Menopause After Cancer Crash Course

Dani Binnington, Menopause and Cancer

A condensed run through the options after cancer treatment — what's on the table, what isn't, and how to raise it with your oncology team. Six short episodes you can watch one at a time.

Watch on YouTube

Watch: expert talk

16 minInternational Menopause Society

Scientific advances in early cancer detection: what the future holds

Dr. Lisa Larkin, interviewed by Dr. Marla Shapiro

A short, hopeful update on where early-detection science is heading in midlife, including multi-cancer blood tests, and how to think about surveillance without spiralling.

Watch on YouTube

What do I do next?

Pick one. Today, not someday.

  1. Track it for two weeks

    Start a daily log for the menopause after cancer pattern. Two weeks of dots makes a pattern visible, and gives you something concrete to bring to a doctor or specialist.

    Open symptom log

  2. Read the related guide

    This sits inside a bigger picture. all doorways walks through the wider pattern and the trade-offs.

    Open all doorways

  3. Find the right kind of help

    The right help in midlife often isn't one doctor, it's a small team. Browse a directory pre-filtered to the modality that matches this guide.

    Find care

  4. Talk to your doctor

    Use the printable conversation script: what to say, what to ask for, and how to ask for a second opinion if the first appointment didn't land.

    Open conversation script

Other pathways

These often show up alongside this one.

Newer evidence and current guidance

Evidence checked 12 October 2026. Older landmark trials remain relevant alongside these updates.

Pooled observational studies found no overall increase in recurrence with vaginal estrogen.

Systematic reviewAmerican Journal of Obstetrics and Gynecology · 2025

Beste et al.; 8 observational studies, 24,060 patients in the recurrence analysis

Published online November 2024, in the March 2025 issue. The review pooled unadjusted estimates, so differences between users and non-users can influence results. It doesn't prove a protective effect or settle safety during aromatase inhibitor treatment.

Read the source

Vaginal estrogen wasn't associated with higher early breast cancer-specific mortality.

Cohort studyJAMA Oncology · 2024

McVicker et al.; 49,237 women in Scotland and Wales

Published online November 2023, in the January 2024 issue. This study assessed deaths, not recurrence; those are different outcomes. Observational evidence can't establish causation. Funded by Cancer Research UK.

Read the source

After breast cancer, consider vaginal estrogen when non-hormonal care hasn't helped enough.

Clinical guidelineNICE NG23 · 2026

Survivorship recommendations were updated in 2024. Recurrence risk remains uncertain after estrogen receptor-positive cancer. People on aromatase inhibitors should identify options with a breast cancer specialist. Low-dose local treatment and systemic MHT are separate decisions.

Read the source
For doctors and specialists

Clinical resources

Written for doctors and specialists, and open to anyone. Handy to bring to an appointment if you'd like to talk it through together.